Status:
COMPLETED
The MS-LINK™ Outcomes Study
Lead Sponsor:
EMD Serono Research & Development Institute, Inc.
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
The Multiple Sclerosis (MS) Leadership and Innovation Network (MS-LINK™) is comprised of networks working cooperatively to advance Multiple Sclerosis (MS) science and improve MS participant outcomes. ...
Eligibility Criteria
Inclusion
- Participants willing and able to provide written informed consent
- Participants willing to be contacted while participating in the study for recruitment into sub-studies that may be relevant to them
- Participants willing and able to complete PROs on a monthly basis and document events of interest as they occur
- Participants willing to participate in additional follow up at the site for at least three years
Exclusion
- Unable to complete questionnaires in English
- Unable to consistently access the Internet
- Participants participating in interventional clinical drug trials at baseline
Key Trial Info
Start Date :
March 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
2182 Patients enrolled
Trial Details
Trial ID
NCT04735406
Start Date
March 24 2021
End Date
May 31 2024
Last Update
August 22 2024
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Alabama Neurology Associates
Birmingham, Alabama, United States, 35209
2
Georgetown University
Washington D.C., District of Columbia, United States, 20057
3
Atlanta Neuroscience Institute
Atlanta, Georgia, United States, 30327
4
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215